Fate Therapeutics Inc
NASDAQ:FATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
DevEx Resources Ltd
ASX:DEV
|
AU |
Intrinsic Value
The intrinsic value for
Fate Therapeutics Inc (FATE) under the Base Case is 0.11 USD.
Compared with the current market price of 2.65 USD, the stock appears
Overvalued by 96% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Fate Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Fate Therapeutics Inc
Earnings Waterfall
Fate Therapeutics Inc
The intrinsic value for
Fate Therapeutics Inc (FATE) under the Base Case is 0.11 USD.
Compared with the current market price of 2.65 USD, the stock appears Overvalued by 96% .